Does MECASERMIN Cause Product dose omission issue? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Product dose omission issue have been filed in association with MECASERMIN (GUNA-IGF). This represents 4.6% of all adverse event reports for MECASERMIN.
22
Reports of Product dose omission issue with MECASERMIN
4.6%
of all MECASERMIN reports
0
Deaths
2
Hospitalizations
How Dangerous Is Product dose omission issue From MECASERMIN?
Of the 22 reports, 2 (9.1%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MECASERMIN. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does MECASERMIN Cause?
Off label use (117)
Headache (41)
Hypoglycaemia (36)
Blood glucose decreased (32)
Drug dose omission (27)
Injection site pain (26)
Vomiting (26)
Fatigue (25)
Pyrexia (23)
Decreased appetite (22)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which MECASERMIN Alternatives Have Lower Product dose omission issue Risk?
MECASERMIN vs MECHLORETHAMINE
MECASERMIN vs MECLIZINE
MECASERMIN vs MEDROL
MECASERMIN vs MEDROXYPROGESTERONE
MECASERMIN vs MEDROXYPROGESTERONE\MEDROXYPROGESTERONE